Arak, H., & Kuş, T. (2024). Prognostic and Predictive Significance of HER2-low Expression in Metastatic Hormone Receptor Positive Breast Cancer Patients Receiving CDK4-6 Inhibitor Therapy. European Journal of Therapeutics. https://doi.org/10.58600/eurjther2151